Abstract:OBJECTIVE:To evaluate the efficacy and safety of dydrogesterone in the treatment of threatened miscarriage.METHODS:Randomized controlled trials(RCT) involving dydrogesterone in the treatment of threatened miscarriage were identified from PubMed,Embase,Cochrane Central,CBM,CNKI,VIP,ClinicalTrials.gov and WHO ICTRP.Published and unpublished RCTs were obtained on dydrogesterone in the treatment of threatened miscarriage.Included literatures were extracted and bias risks were evaluated independently by two reviewers.RevMan 5.0 software was used for Meta-analysis.RESULTS:A total of 8 RCT involving 1 185 participants were included.Dydrogesterone vs.conservative treatment:4 RCT were included,the results of Meta-analysis showed that participants treated with dydrogesterone had a lower risk of miscarriage,compared with conservative treatment [RR=0.46,95%CI(0.32,0.65),P0.000 1];no statistical significance was found in the incidence of premature birth(P=0.77),antepartum haemorrhage(P=0.57) and congenital malformation(P=0.71).Dydrogesterone vs.progesterone:2 RCT were included.We did not conduct Meta-analysis as included studies were in high risk of bias.No statistical significance was reported between two groups in the incidence of miscarriage(P=1.000 and P=0.630).Dydrogesterone vs.HCG:1 RCT was included.No statistical significance was reported between two groups regarding to the incidence of miscarriage(P=0.711),premature birth(P=0.727) and congenital malformation(P=0.461).Dydrogesterone combined with TCM treatment:2 RCT were included,the incidences of miscarriage in dydrogesterone combined with Zishen yutai pills group and dydrogesterone alone group were 8% and 13%,there was no statistical significance(P=0.655);miscarriage occurred in 7.5% of women treated with dydrogesterone combined with Bushen huoxue antai prescription,and in 15% of that treated with progesterone,without statistical significance,neither(P=0.390).CONCLUSION:Dydrogesterone group has a lower incidence of miscarriage than conservative treatment only,but further studies with good methodological design are still needed to investigate its efficacy.There is no sufficient evidence to show any negative outcomes occurred in mothers or children related to dydrogesterone.Current studies with poor methodological quality show no difference in the efficacy between dydrogesterone and progesterone or HCG.There is insufficient evidence to show the benefit of dydrogesterone combined with TCM.

Correlation between taking dydrogesterone in the first trimester and preeclampsia in singleton pregnancy following fresh cycle assisted reproduction

Pregnancy-related complications and perinatal outcomes following progesterone supplementation before 20 weeks of pregnancy in spontaneously achieved singleton pregnancies: a systematic review and meta-analysis

Correlative Research of the Incidence of Preeclampsia and Sperm Exposure.

Study on Correlation between Changes in Coagulation and Fibrinolysis Related Factors and Incidence of Severe Pre-eclampsia

Recurrent Ivf Failure Is Associated With Elevated Progesterone On The Day Of Hcg Administration

CONGENITAL ANOMALIES AFTER FIRST-TRIMESTER DYDROGESTERONE THERAPY DURING IN VITRO FERTILIZATION.

Ri sk factors fo recurrent preeclampsia and i ts relation ot mta ernal and fo fspring outcome

[Risk Factors of Recurrent Preeclampsia and Its Relation to Maternal and Offspring Outcome].

Congenital Anomalies after First-Trimester Dydrogesterone Therapy During in Vitro Fertilization: a Retrospective Cohort Study

Effects of dydrogesterone using for luteal phase support on IVF obstetric outcomes

Elevated Follicular Cortisone Level is a Negative Predictor of Clinical Pregnancy in Women Undergoing Fresh Embryo Transfer

Correlation between in vitro fertilization-embryo transfer and preeclampsia

Clinical features of recurrent preeclampsia: a retrospective study of 109 recurrent preeclampsia patients

Correlation between blood lipid levels in early pregnancy and preeclampsia

First-Trimester Serum Targeted Metabolomics for Eicosanoids Reveals Predictive Potential and Preventive Targets for Severe Preeclampsia: A Nested Prospective Cohort Study

Maternal Serum Homocysteine and Lipids in First Trimester for Prediction of Severe Preeclampsia

Correlation Analysis of Serum Lipids and Serum Vitamin A, E Levels with Preeclampsia during Pregnancy

Association of Gestational Vitamin E Status With Pre-eclampsia: A Retrospective, Multicenter Cohort Study

Dydrogesterone for Threatened Miscarriage:A Systematic Review

Comparison of the effect of dydrogesterone and natural micronized progesterone for luteal-phase support in assisted reproductive technology cycles: A single-blind randomized clinical trial study

Efficacy of serum markers and hemodynamic index of bilateral uterine arteries to predict preeclampsia in first trimester of pregnancy